Mark Hahn

Equitel, Inc. provides prepaid telecommunications services. It provides cellular telephone, prepaid telephony solutions to retailers, distributors, communications service providers, business service providers, and consumers. Equitel was founded in 1999 and is headquartered in Raleigh, NC.

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

Gigabeam Corp. engages in the provision of fixed wireless communication equipment. It produces, leases, installs and services multi-gigabit wireless communications equipment. The company was founded by Louis S. Slaughter and Douglas G. Lockie on January 5, 2004 and is headquartered in Herndon, VA.

Athenix Corp. develops agricultural herbicide tolerance and insect control chemicals. It provides genes, proteins, processes, traits, and transgenic organisms for multiple sectors including seed, agricultural chemical, specialty chemical, industrial enzymes, and energy. The company was founded by Duck Nicholas Barbara, Carozzi Nadine and Koziel Michael Gene in 2001 and is headquartered in Raleigh, NC.

Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC.

Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC.

Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC.